InsidersTradesSigma
Track the 바이오니아 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 바이오니아 has recorded 1 public disclosures. Market capitalisation: €161.6bn. The latest transaction was disclosed on 4 March 2026 (Other). Among the most active insiders: 바이오니아. The full history is openly available.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 18,369 of 29,064 companies
43.7
score / 100
Value42
Quality45
FCF yld2.0%
Earn yld-1.7%
EV/EBITDA11.4x
ROE·
Gross mgn78%
Net mgn-0.9%
Debt/EBITDA4.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 March 2026
Acerca de 바이오니아
BioNia es una empresa que opera en el sector de la salud y farmacéutico, cotizada en el mercado XKRX. Se centra en el desarrollo de soluciones biofarmacéuticas innovadoras.